| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Jul | ||||||
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
Multaq Approval Marks Comeback for Sanofi's Heart Drug
2 Jul 2009 18:00, WSJ.com
... seven years, according to . Late last year, Sanofi decided to of obesity drug Acomplia, which was once thought to have much promise. Lately, the company has faced questions ...
Click for the latest world news headlines from EIN News
BUYINS.NET: BLUD, NVO, RBN, ROS, SNY, CPII. Abnormal Price Friction In Morning Trading Session Today
26 Jun 2009 16:33, Tradingcharts.com
... internal medicine, and vaccines. Its primary medicines include Lovenox/Clexane, Plavix/Iscover, Aprovel/Avapro/Karvea, Tritace/Triatec/Delix/Altace, Lantus, Amaryl/Amarel/Solosa, Acomplia, Taxotere, Eloxatine, Stilnox/Ambien/Myslee, Copaxone, Depakine, Allegra/Telfast, Nasacort, Xatral/Uroxatral, and Actonel/Optinate/Acrel. The companys vaccines principally ...
The UK National Institute for Health and Clinical Excellence (NICE) has approved the use of anti-obesity drug Acomplia (Rimonabant). The green light was given after the medication received positive appraisal from the institute in March.
Acomplia is recommended as an addition to exercise and proper diet for obese and overweight patients who found two other weight-loss medications Reductil (orlistat) and Xenical (sibutramine) ineffective. Now Acomplia can be prescribed by doctors from the state healthcare system of the UK. However, the drug still has to wait for approval in Germany and the United States. Sanofi-Aventis the manufacturer of Acomplia sais they expect that new clinical trials in Type 2 diabetes patients will influence the approval process.
continue reading "Acomplia Finally Gets OK for the UK"
Wordpress by DrugsPill.com